-
1
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
-
Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 288:2002;321-333
-
(2002)
J. Am. Med. Assoc.
, vol.288
, pp. 321-333
-
-
Rossouw, J.E.1
Anderson, G.L.2
Prentice, R.L.3
-
2
-
-
0042093742
-
Estrogen plus progestin and the risk of coronary heart disease
-
Manson J.E., Hsia J., Johnson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349:2003;523-534
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 523-534
-
-
Manson, J.E.1
Hsia, J.2
Johnson, K.C.3
-
3
-
-
0037830132
-
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative Randomized Trial
-
Chlebowski R.T., Hendrix S.L., Langer R.D., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative Randomized Trial. J. Am. Med. Assoc. 289:2003;3243-3253
-
(2003)
J. Am. Med. Assoc.
, vol.289
, pp. 3243-3253
-
-
Chlebowski, R.T.1
Hendrix, S.L.2
Langer, R.D.3
-
4
-
-
0042018741
-
Breast cancer and hormone replacement therapy in the Million Women Study
-
Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419-27.
-
(2003)
Lancet
, vol.362
, pp. 419-427
-
-
-
5
-
-
0032547326
-
Randomized trial of estrogen plus progestin for secondary prevention of coronary disease in postmenopausal women
-
Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary disease in postmenopausal women. J. Am. Med. Assoc. 280:1998;605-613
-
(1998)
J. Am. Med. Assoc.
, vol.280
, pp. 605-613
-
-
Hulley, S.1
Grady, D.2
Bush, T.3
-
6
-
-
0034710627
-
Effects of estrogen replacement on the progression of coronary artery atherosclerosis
-
Herrington D.M., Reboussin D.R., Brosnihan K.B., et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N. Engl. J. Med. 343:2000;522-529
-
(2000)
N. Engl. J. Med.
, vol.343
, pp. 522-529
-
-
Herrington, D.M.1
Reboussin, D.R.2
Brosnihan, K.B.3
-
7
-
-
0012868624
-
Effects of estrogen plus progestin on health-related quality of life
-
Hays J., Ockene J.K., Brunner R.L., et al. Effects of estrogen plus progestin on health-related quality of life. N. Engl. J. Med. 348:2003;1839-1854
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 1839-1854
-
-
Hays, J.1
Ockene, J.K.2
Brunner, R.L.3
-
8
-
-
1642332489
-
Early initiation of hormone therapy and clinical cardioprotection: The Women's Health Initiative (WHI) could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition
-
in press.
-
Naftolin F, Taylor HS, Karas R. Early initiation of hormone therapy and clinical cardioprotection: the Women's Health Initiative (WHI) could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril, 2004, in press.
-
(2004)
Fertil Steril
-
-
Naftolin, F.1
Taylor, H.S.2
Karas, R.3
-
9
-
-
3042687002
-
Effects of hormone replacement therapy on the risks of breast cancer and cardiovascular disease: The validity of the epidemiological evidence
-
Schneider HPG, Naftolin F, editors. Climacteric medicine - Where do we go? London: Parthenon Publishing; in press.
-
Shapiro S, Effects of hormone replacement therapy on the risks of breast cancer and cardiovascular disease: the validity of the epidemiological evidence. In: Schneider HPG, Naftolin F, editors. Climacteric medicine - Where do we go? Proceedings of the 4th Workshop of the International Menopause Society. London: Parthenon Publishing; 2004, in press.
-
(2004)
Proceedings of the 4th Workshop of the International Menopause Society
-
-
Shapiro, S.1
-
10
-
-
0347509279
-
Considerations in interpreting the cardiovascular effects of hormone replacement therapy observed in the WHI: Timing is everything
-
Karas R.H., Clarkson T.B. Considerations in interpreting the cardiovascular effects of hormone replacement therapy observed in the WHI: timing is everything. Menopausal Med. 10:2003;8-12
-
(2003)
Menopausal Med.
, vol.10
, pp. 8-12
-
-
Karas, R.H.1
Clarkson, T.B.2
-
11
-
-
0034687825
-
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease
-
Grodstein F., Manson J.E., Colditz G.A., Willett W.C., Speizer F.E., Stampfer M.J. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann. Intern. Med. 133:2000;933-941
-
(2000)
Ann. Intern. Med.
, vol.133
, pp. 933-941
-
-
Grodstein, F.1
Manson, J.E.2
Colditz, G.A.3
Willett, W.C.4
Speizer, F.E.5
Stampfer, M.J.6
-
13
-
-
0034063090
-
Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis
-
Joakimsen O., Bønaa K.H., Stensland-Bugge E., Jacobsen B.K. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis. J. Clin. Epidemiol. 53:2000;525-530
-
(2000)
J. Clin. Epidemiol.
, vol.53
, pp. 525-530
-
-
Joakimsen, O.1
Bønaa, K.H.2
Stensland-Bugge, E.3
Jacobsen, B.K.4
-
14
-
-
0034710639
-
Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women
-
Hu F.B., Stampfer M.J., Manson J.E., et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N. Engl. J. Med. 343:2000;530-537
-
(2000)
N. Engl. J. Med.
, vol.343
, pp. 530-537
-
-
Hu, F.B.1
Stampfer, M.J.2
Manson, J.E.3
-
15
-
-
0038742057
-
Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: Results from the estrogen in the prevention of atherosclerosis trial
-
Mack W.J., Hameed A.B., Xiang M., et al. Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial. Atherosclerosis. 168:2003;91-98
-
(2003)
Atherosclerosis
, vol.168
, pp. 91-98
-
-
MacK, W.J.1
Hameed, A.B.2
Xiang, M.3
-
16
-
-
0025223339
-
Inhibition of coronary atherosclerosis by 17β-estradiol in ovariectomized monkeys: Lack of an effect of added progesterone
-
Adams M.R., Kaplan J.R., Manuck S.B., et al. Inhibition of coronary atherosclerosis by 17β-estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 10:1990;1051-1057
-
(1990)
Arteriosclerosis
, vol.10
, pp. 1051-1057
-
-
Adams, M.R.1
Kaplan, J.R.2
Manuck, S.B.3
|